Volibo R 0.2/0.5 mg

Volibo R 0.2/0.5 mg is a combination of Voglibose and Repaglinide, which belongs to the group of drugs known as antidiabetic agents. It is combined with diet and exercise to treat patients with Type 2 diabetes. Type 2 diabetes is when body cells do not respond to insulin (a hormone that helps regulates how your body uses sugar) normally. This causes high blood sugar level that further leads to serious health conditions. The combined action of two active ingredients is given below: — Voglibose is an alpha-glucosidase inhibitor, which works by inhibiting intestinal enzymes and delaying the digestion and absorption of carbohydrates in the intestines. This stops the breakdown of complex sugars into simple sugar such as glucose. — Repaglinide increases the amount of insulin produced by the pancreas by stimulating the release of insulin and helps regulate the amount of sugar in the bloodstream. — Collectively, the fixed combination drug prevents a rise in blood sugar levels after having meals.